scholarly journals Quantitative muscle MRI and functional measures in a cohort of late onset GSD II patients

2013 ◽  
Vol 14 (S2) ◽  
Author(s):  
O Musumeci ◽  
M Gaeta ◽  
E Barca ◽  
A Mileto ◽  
G Vita ◽  
...  
2013 ◽  
Vol 14 (S2) ◽  
Author(s):  
E Barca ◽  
O Musumeci ◽  
C Rodolico ◽  
A Ciranni ◽  
G Vita ◽  
...  

2019 ◽  
Vol 29 ◽  
pp. S59-S60
Author(s):  
C. Nuñez-Peralta ◽  
J. Alonso-Pérez ◽  
S. Segovia ◽  
J. Llauger ◽  
P. Montesinos ◽  
...  

2020 ◽  
Vol 129 (2) ◽  
pp. S88
Author(s):  
Aleena A. Khan ◽  
Tracy Boggs ◽  
Michael Bowling ◽  
Stephanie Austin ◽  
Mihaela Stefanescu ◽  
...  

2021 ◽  
Author(s):  
annalisa carlucci ◽  
nicola Barbarito ◽  
alberto malovini ◽  
piero ceriana ◽  
serena cirio ◽  
...  

Abstract Background Respiratory dysfunction in Late Onset Pompe Disease (LOPD) is attributed primarily to diaphragm weakness; it is not always proportional to skeletal muscle weakness. Beyond diaphragm and rib cage muscles, we know that posterior trunk muscles participate to inspiration, and abdominal wall muscles contribute to forced expiration. We aimed to investigate whether the involvement of axial muscles detected by muscle MRI may correlate with respiratory dysfunction or influence respiratory functional tests. Methods In 19 patients with LOPD in different stages of disease, we analyzed trunk muscle MRI and upright forced vital capacity FVC, postural drop in VC, and maximal inspiratory and expiratory pressures (MIP, MEP). Results While upright FVC did not correlate with trunk muscle involvement, postural drop in VC, reflecting diaphragm weakness, was strongly influenced by the severity of involvement of all posterior and anterior muscles. Conclusion Trunk muscles involvement in LOPD may reveal respiratory dysfunction and contribute to postural drop in VC. It is likely that axial muscle weakness may impair the compensatory mechanisms occurring in clinostatism, and mainly operated by the abdominal muscles. Detection of axial muscle damage by MRI may thus suggest the need of more extensive respiratory assessment, i.e. by polysomnography, even when upright VC is still within normal ranges.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Sebastian Figueroa-Bonaparte ◽  
◽  
Jaume Llauger ◽  
Sonia Segovia ◽  
Izaskun Belmonte ◽  
...  

2011 ◽  
Vol 21 (11) ◽  
pp. 791-799 ◽  
Author(s):  
Robert-Yves Carlier ◽  
Pascal Laforet ◽  
Claire Wary ◽  
Dominique Mompoint ◽  
Kenza Laloui ◽  
...  

Neurology ◽  
2018 ◽  
Vol 90 (5) ◽  
pp. e412-e418 ◽  
Author(s):  
Emma Matthews ◽  
Christoph Neuwirth ◽  
Fatima Jaffer ◽  
Renata S. Scalco ◽  
Doreen Fialho ◽  
...  

ObjectiveTo characterize the phenotype of patients with symptoms of periodic paralysis (PP) and ryanodine receptor (RYR1) gene mutations.MethodsCases with a possible diagnosis of PP but additional clinicopathologic findings previously associated with RYR1-related disorders were referred for a tertiary neuromuscular clinical assessment in which they underwent detailed clinical evaluation, including neurophysiologic assessment, muscle biopsy, and muscle MRI. Genetic analysis with next-generation sequencing and/or targeted Sanger sequencing was performed.ResultsThree cases with episodic muscle paralysis or weakness and additional findings compatible with a RYR1-related myopathy were identified. The McManis test, used in the diagnosis of PP, was positive in 2 of 3 cases. Genetic analysis of known PP genes was negative. RYR1 analysis confirmed likely pathogenic variants in all 3 cases.ConclusionsRYR1 mutations can cause late-onset atypical PP both with and without associated myopathy. Myalgia and cramps are prominent features. The McManis test may be a useful diagnostic tool to indicate RYR1-associated PP. We propose that clinicopathologic features suggestive of RYR1-related disorders should be sought in genetically undefined PP cases and that RYR1 gene testing be considered in those in whom mutations in SCN4A, CACNA1S, and KCNJ2 have already been excluded.


2006 ◽  
Vol 37 (6) ◽  
pp. 6
Author(s):  
PATRICE WENDLING
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document